Found vs Hers: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Found and Hers are tied at 7.3/10. Found is more affordable at $264/mo vs $348/mo. Choose Found for users who want a science-backed weight loss program with beh. Choose Hers for women who want glp-1 access from a well-known, publicly trad.
A side-by-side comparison of Found and Hers covering pricing, scores, medication types, insurance, and more to help you decide.
Found
#30 of 40Science-backed weight management platform combining GLP-1 medications with behavioral health coaching and support.
Visit FoundHers
#33 of 40The women's health arm of Hims & Hers Health (NYSE: HIMS), offering compounded GLP-1 medications with a polished app experience designed for women's health needs.
Visit Hers| Feature | Found | Hers |
|---|---|---|
| Our Score | 7.3/10 | 7.3/10 |
| Starting Price | $264/mo | $348/mo |
| Medication Type | Both | Compounded |
| Insurance Accepted | Yes | No |
| Best For | Users who want a science-backed weight loss program with behavior change support | Women who want GLP-1 access from a well-known, publicly traded telehealth brand |
| Ranking | #30 | #33 |
Pros & Cons Compared
Found
Pros
- +Active insurance coordination — Found contacts your insurer and reports which GLP-1s are covered, prior auth requirements, and estimated copay
- +10+ medication options including both compounded and brand-name (Wegovy, Zepbound, Wegovy pill) — the widest formulary of any platform
- +Typical insured copay of ~$30/mo for most members — dramatically lower than cash-pay alternatives
- +Most members start treatment within one week of completing the health questionnaire
Cons
- −Pricing is less transparent than flat-rate competitors — costs vary by insurance status and medication choice
- −The insurance navigation process adds steps and complexity compared to simple cash-pay platforms
- −Compounded medication availability may shift with FDA enforcement changes
Hers
Pros
- +Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
- +Women-focused branding, content, and support — not a men's health platform with a women's tab
- +$199/mo all-inclusive for compounded semaglutide with consultations and free shipping
- +Broader women's health platform — can address hormonal, skin, and wellness needs alongside weight loss
Cons
- −Pivoted away from some compounded formulations after FDA crackdown — medication availability can shift
- −Compounded only — no brand-name Wegovy or Zepbound through the platform
- −Generic support experience — large patient volume means less personalized attention
- −Higher price than competitors like TrimRx ($179) or Enhance MD ($115) for a similar compounded product
Our Verdict
Found and Hers are closely matched with identical scores of 7.3/10. If budget is your priority, Found starts at $264/mo compared to Hers's $348/mo. Found accepts insurance, which can significantly reduce your out-of-pocket costs. Found offers both brand-name and compounded medications, giving you more flexibility. Choose Found if you want: users who want a science-backed weight loss program with behavior change support. Choose Hers if you want: women who want glp-1 access from a well-known, publicly traded telehealth brand.